Bank Of New York Mellon Corp Bio Cardia, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.87 - $2.54 $23,689 - $32,176	12,668 New	12,668 $24.7 Million
Q4 2022 Feb 14, 2023	BUY	$1.61 - $32.1 $20,395 - $406,642	12,668 New	12,668 $26,000
Q2 2022 Aug 15, 2022	SELL	$17.7 - $32.55 $1,539 - $2,831	-87 Reduced 0.68%	12,767 $19,000
Q2 2021 Aug 11, 2021	SELL	$48.9 - $74.85 $114,572 - $175,373	-2,343 Reduced 15.42%	12,854 $0
Q1 2021 May 13, 2021	SELL	$51.3 - $78.15 $56,276 - $85,730	-1,097 Reduced 6.73%	15,197 $0
Q4 2020 Feb 09, 2021	BUY	$28.8 - $100.5 $469,267 - $1.64 Million	16,294 New	16,294 $0

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $41.2M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.